Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis
    2.
    发明申请
    Use of Doxycycline in the Treatment of Idiopathic Pulmonary Fibrosis 审中-公开
    使用强力霉素治疗特发性肺纤维化

    公开(公告)号:US20100130452A1

    公开(公告)日:2010-05-27

    申请号:US12528225

    申请日:2008-02-25

    IPC分类号: A61K31/65 A61P11/00

    摘要: Use of doxycycline, a non specific matrix metalloproteinase inhibitor, for treatment of idiopathic pulmonary fibrosis and a pharmaceutical composition comprising doxycycline or its congener in combination with another compound selected from the drug listed for treatment of idiopathic pulmonary fibrosis in a standard dose.

    摘要翻译: 使用强力霉素,非特异性基质金属蛋白酶抑制剂,用于治疗特发性肺纤维化,以及含有多西环素或其同系物的组合物与选自标准剂量治疗特发性肺纤维化的药物的另一种化合物组合的药物组合物。

    Process for producing herbicides from a fungus Alternaria alternata f.sp. lantanae
    4.
    发明授权
    Process for producing herbicides from a fungus Alternaria alternata f.sp. lantanae 失效
    从真菌Alternaria alteranata f.sp.生产除草剂的方法 兰塔纳

    公开(公告)号:US07585661B2

    公开(公告)日:2009-09-08

    申请号:US10531846

    申请日:2002-10-16

    申请人: Sanjai Saxena

    发明人: Sanjai Saxena

    IPC分类号: A01N63/00

    CPC分类号: C12R1/645 A01N63/04 C12P1/02

    摘要: A process for producing herbicides from a fungus Alternaria alteranata f.sp. lantanae deposited as a pure culture as MTCC 5432 and ITCC-4896, comprising culturing the fungus in a liquid broth; subjecting the broth to the step of filtration to separate the broth containing phytotoxins from mycelium; extracting the phytotoxins from said broth to obtain the phytotoxins; and subjecting the phytotoxins to chemical characterization.

    摘要翻译: 一种从真菌Alternaria alteranata f.sp.生产除草剂的方法。 黄连素作为纯培养物沉积为MTCC 5432和ITCC-4896,包括在液体培养基中培养真菌; 使肉汤进行过滤步骤以将含有植物毒素的肉汤从菌丝体分离; 从所述肉汤中提取植物毒素以获得植物毒素; 并对植物毒素进行化学表征。

    Magnetic resonance measurement
    5.
    发明授权
    Magnetic resonance measurement 失效
    磁共振测量

    公开(公告)号:US5374889A

    公开(公告)日:1994-12-20

    申请号:US217128

    申请日:1994-03-24

    摘要: In nuclear magnetic resonance spectroscopy spatial localization of the output signal is achieved by using gradient magnetic fields and radio-frequency inversion pulses to define slices through a sample from which a signal is obtained. The use of intersecting slices allows the field of view to be reduced to the region of intersection to study a localized volume of interest in the sample. Conventionally, three orthogonal gradient magnetic fields can be defined by energizing successively three gradient magnetic field coils. With the present invention combinations of the gradient magnetic field coils are energized simultaneously to allow the field of view to be more closely conformed to a described volume of interest. This simultaneous energization allows the field of view to be rotated relative to the axes of the coils and/or allows non-orthogonal intersecting slices to be defined to alter the shape of the field of view at the intersection of the slices. Further, more than three slices may be defined to allow polyhedral fields of view to be defined. The invention is applicable to many modern forms of nuclear magnetic resonance spectroscopy.

    摘要翻译: PCT No.PCT / GB89 / 00966 Sec。 371日期1991年04月22日 102(e)日期1991年4月22日PCT PCT 1989年8月18日PCT公布。 出版物WO90 / 02344 1990年3月8日。在核磁共振谱中,通过使用梯度磁场和射频反转脉冲来定义通过从其获得信号的样本的切片来实现输出信号的空间定位。 使用相交的切片允许将视野减小到交叉区域以研究样本中的局部感兴趣体积。 通常,可以通过依次激励三个梯度磁场线圈来定义三个正交梯度磁场。 利用本发明,梯度磁场线圈的组合被同时通电,以允许视场更紧密地符合所述感兴趣的体积。 这种同时通电允许视野相对于线圈的轴线旋转和/或允许定义非正交交叉切片以改变切片交叉处的视场的形状。 此外,可以定义多于三个切片以允许定义多面体视场。 本发明适用于许多现代形式的核磁共振光谱。

    Avian control
    7.
    发明授权
    Avian control 失效
    禽类控制

    公开(公告)号:US5196451A

    公开(公告)日:1993-03-23

    申请号:US793292

    申请日:1991-11-14

    摘要: Compounds of formula (I), wherein X.sup.1 and X.sup.5 are each separately selected from hydrogen and C.sub.1-4 alkyl, halogeno and halogeno-substituted C.sub.1-4 alkyl groups: X.sup.2, X.sup.3 and X.sup.4 are each separately selected from hydrogen and C.sub.1-4 alkyl, hydroxy, C.sub.1-4 alkoxy and phenoxy groups; R.sup.1 and R.sup.2 are each separately selected from hydrogen and C.sub.1-4 alkyl groups; R.sup.3 and R.sup.4 are each hydrogen or together constitute the second bond of a carbon-carbon double bond joining --CR.sup.1 R.sup.3 and --CR.sup.2 R.sup.4 ; and Y is hydroxymethyl, formyl, cyano, carbamoyl, carbamoyl N-substituted by one or two of the same or different C.sub.1-4 alkyl groups, carboxy or a carboxylic ester or carboxylate salt, are of value as avian repellents.

    摘要翻译: 式(I)化合物,其中X 1和X 5各自独立地选自氢和C 1-4烷基,卤代和卤代取代的C 1-4烷基:X 2,X 3和X 4各自独立地选自氢和C 1-4烷基 ,羟基,C 1-4烷氧基和苯氧基; R 1和R 2各自独立地选自氢和C 1-4烷基; R3和R4各自为氢或一起构成连接-CR1R3和-CR2R4的碳 - 碳双键的第二键; 并且Y是羟基甲基,甲酰基,氰基,氨基甲酰基,被一个或两个相同或不同的C 1-4烷基,羧基或羧酸酯或羧酸盐N-取代的氨基甲酰基,作为防水剂是有价值的。

    Dentine protection
    8.
    发明授权
    Dentine protection 失效
    牙齿保护

    公开(公告)号:US5192362A

    公开(公告)日:1993-03-09

    申请号:US735752

    申请日:1991-07-29

    摘要: To combat the accumulation of plaque on dentures, a non self-supporting coating of a non-toxic, negatively charged polysaccharide is applied. The polysaccharide coating is gradually sacrificed or ablated during wear. Ablation appears to remove microorganisms along with coating material. The polysaccharide is further defined by an ability to reduce the adhesion of Streptococcus salivarius cells in a simple in vitro bacterial adhesion test by at least 25% over a control.

    摘要翻译: PCT No.PCT / GB89 / 00134 Sec。 371 1990年6月29日第 102(e)日期1990年6月29日PCT提交1989年2月10日PCT公布。 出版物WO89 / 07437 日期1989年8月24日。为了对抗假牙上斑块的积累,应用无毒,带负电荷的多糖的非自支撑涂层。 多糖涂层在磨损期间逐渐被牺牲或消融。 消融似乎与涂层材料一起除去微生物。 多糖还通过在简单的体外细菌粘附试验中将唾液链球菌细胞的粘附力降低至少25%以上的能力来定义。

    Fowlpox virus promoters
    9.
    发明授权
    Fowlpox virus promoters 失效
    FOWLPOX病毒促销

    公开(公告)号:US5182210A

    公开(公告)日:1993-01-26

    申请号:US469608

    申请日:1990-04-17

    CPC分类号: C12N15/86 C12N2710/24043

    摘要: Fowlpox virus (FPV) promoter DNA for use in expressing a foreign gene inserted in a FPV vector by homologous recombination, which comprises the promoter of any of the following FPV genes:(1) The FB4b gene which encodes a protein of about 657 amino acids in a sequence beginning ##STR1## (2) The BamHI fragment ORF8 gene encoding a protein of about 116 amino acids in a sequence beginning ##STR2## (3) The BamHI fragment ORF5 gene encoding a protein of about 105 amino acids in a sequence beginning ##STR3## (4) The BamHI fragment ORF10 gene encoding a protein of about 280 amino acids in a sequence beginning ##STR4##

    摘要翻译: PCT No.PCT / GB88 / 00922 Sec。 371日期:1990年04月17日 102(e)日期1990年04月17日PCT提交1988年10月21日PCT公布。 出版物WO89 / 03879 日期:1989年5月5日。用于表达通过同源重组插入FPV载体中的外源基因的痘病毒(FPV)启动子DNA,其包含以下任一FPV基因的启动子:(1)编码 (2)序列开始编码约116个氨基酸的蛋白质的BamHI片段ORF8基因Met Glu Glu Gly Lys Pro Arg Arg Ser Ser Ala Val Leu Trp Met Leu Ile Pro Cys Gly; (3)编码序列开始的序列中的约105个氨基酸的蛋白质的BamHI片段ORF5基因,即Met Ile Ile Arg Arg Asn Asn Lys Ala Leu Gly Ser Val Met Ser Asp Phe Ile Lys Thr; 和(4)编码序列开始的序列中约280个氨基酸的蛋白质的BamHI片段ORF10基因Met Lys Phe Lys Glu Val Arg Asn Thr Ile Lys Lys Met Asn Ile Thr Asp Ile Lys Ile。

    Pharmaceutical compositions for treating certain cancers
    10.
    发明授权
    Pharmaceutical compositions for treating certain cancers 失效
    用于治疗某些癌症的药物组合物

    公开(公告)号:US5162372A

    公开(公告)日:1992-11-10

    申请号:US674297

    申请日:1991-03-25

    IPC分类号: A61K31/225 C07D317/68

    CPC分类号: C07C255/00 C07D317/68

    摘要: Compounds of formula (II) ##STR1## wherein R.sub.1 and R.sub.2 are each separately selected from hydrogen, alkyl, alkenyl and alkynyl groups having up to a maximum of four carbon atoms and being unsubstituted, and alkyl, alkenyl and alkynyl groups having up to a maximum of three carbon atoms and being substituted by one, or in the case of fluoro by one or more, substituents but with the proviso that when R.sub.1 is hydrogen then R.sub.2 is hydrogen or methyl, or R.sub.1 and R.sub.2 together constitute an ethylene bridging group, and R.sub.3 is a group which under physiological conditions undergoes elimination with the formation of a 3,5-dioxopiperazinyl ring, with the further proviso that the compound is in the meso or erythro configuration when each of R.sub.1 and R.sub.2 is the same or different unsubstituted or substituted alkyl, alkenyl or alkynyl group, and salts thereof with a physiologically acceptable inorganic or organic acid, are of value as prodrugs, particularly in the therapy of cancers sensitive to the compounds of formula (II) and psoriasis.

    摘要翻译: 式(II)化合物其中R 1和R 2各自独立地选自氢,烷基,烯基和具有最多四个碳原子的炔基并且是未被取代的烷基,烯基和炔基,其具有 最多三个碳原子,并且被一个取代基取代,或在氟的情况下被一个或多个取代基取代,但条件是当R 1是氢时,R 2是氢或甲基,或者R 1和R 2一起构成乙烯 桥接基团,并且R 3是在生理条件下经历消除形成3,5-二氧代哌嗪基的基团,进一步的条件是当R 1和R 2各自相同或相同时,化合物为中等或赤型构型, 不同的未取代或取代的烷基,烯基或炔基及其盐与生理上可接受的无机或有机酸具有价值作为前药,特别是在治疗对化合物敏感的癌症 的式(II)和牛皮癣。